Format

Send to

Choose Destination
Magn Reson Med. 2016 May;75(5):2107-11. doi: 10.1002/mrm.26151. Epub 2016 Feb 18.

Safety and technique of ferumoxytol administration for MRI.

Author information

1
Department of Radiology, Stanford University, Stanford, CA.
2
Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles.
3
Department of Radiology, University of California, San Francisco.
4
Department of Radiology, Mayo Clinic Florida, Jacksonville, FL.
5
Departments of Radiology, Medical Physics, Biomedical Engineering, and Emergency Medicine, University of Wisconsin, Madison, WI.
6
Center for Advanced Magnetic Resonance Development and Department of Radiology, Duke University, Durham, NC.

Abstract

Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini-review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration.

KEYWORDS:

contrast agent; ferumoxytol; iron oxide; safety

PMID:
26890830
PMCID:
PMC4854636
DOI:
10.1002/mrm.26151
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center